» Authors » Marc Schneider

Marc Schneider

Explore the profile of Marc Schneider including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 193
Citations 2621
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Shehu K, Schneider M, Kraegeloh A
Antibiotics (Basel) . 2025 Feb; 14(2). PMID: 40001407
Antibiotic resistance in chronic lung infections caused by requires alternative approaches to improve antibiotic efficacy. One promising approach is the use of adjuvant compounds that complement antibiotic therapy. This study...
2.
Akpinar Adscheid S, Rojas-Rodriguez M, Abdel-Hafez S, Pavone F, Schneider M, Tureli A, et al.
Pharmaceutics . 2025 Jan; 17(1). PMID: 39861735
: Drug delivery systems (DDSs) offer efficient treatment solutions to challenging diseases such as central nervous system (CNS) diseases by bypassing biological barriers such as the blood-brain barrier (BBB). Among...
3.
Akpinar Adscheid S, Tureli A, Gunday-Tureli N, Schneider M
Beilstein J Nanotechnol . 2024 Nov; 15:1400-1414. PMID: 39559726
Central nervous system diseases negatively affect patients and society. Providing successful noninvasive treatments for these diseases is challenging because of the presence of the blood-brain barrier. While protecting the brain's...
4.
Martins Andrade J, Weiss A, Cunha-Filho M, Gelfuso G, Gratieri T, Schneider M
Int J Pharm . 2024 Nov; 667(Pt A):124906. PMID: 39505242
Hair follicles (HFs) represent a route of interest to drug delivery for treating several skin conditions. Iontophoresis, on the other hand, is a physical method to enhance drug permeation by...
5.
Deutschmeyer V, Schlaudraff N, Walesch S, Moyer J, Sokol A, Graumann J, et al.
Int J Cancer . 2024 Sep; 156(2):353-367. PMID: 39344659
Of the seven in absentia homologue (SIAH) family, three members have been identified in the human genome. In contrast to the E3 ubiquitin ligase encoding SIAH1 and SIAH2, little is...
6.
Abdel-Hafez S, Gallei M, Wagner S, Schneider M
Eur J Pharm Biopharm . 2024 Sep; 204:114512. PMID: 39332746
The use of inhalable nanoparticulate-based systems in the treatment of lung cancer allows for efficient localized delivery to the lungs with less undesirable systemic exposure. For this to be attained,...
7.
Stella J, Abdelaal M, Kamal M, Shehu K, Alhayek A, Haupenthal J, et al.
Eur J Pharm Sci . 2024 Sep; 202:106891. PMID: 39233259
Pulmonary fibrosis, a disabling lung disease, results from the fibrotic transformation of lung tissue. This fibrotic transformation leads to a deterioration of lung capacity, resulting in significant respiratory distress and...
8.
Neuzillet Y, Raynaud J, Dreyfus J, Radulescu C, Rouanne M, Schneider M, et al.
Eur Urol Oncol . 2024 Aug; PMID: 39209681
Background And Objective: Failure rates after first-line treatment of localized prostate cancer (PCa) treatment remain high; therefore, it is essential to improve the selection and identification of at-risk patients to...
9.
Glauche F, Selbmann F, Guttmann M, Schneider M, Hengsbach S, Joseph Y, et al.
Polymers (Basel) . 2024 Aug; 16(15). PMID: 39125244
This study aims to establish and optimize a process for the fabrication of 3D microstructures of the biocompatible polymer Parylene C using hot embossing techniques. The different process parameters such...
10.
Kluck S, Prediger R, Hambitzer L, Nekoonam N, Dreher F, Luitz M, et al.
Adv Sci (Weinh) . 2024 Jul; 11(35):e2405320. PMID: 38995232
The growing importance of submicrometer-structured surfaces across a variety of different fields has driven progress in light manipulation, color diversity, water-repellency, and functional enhancements. To enable mass production, processes like...